122 related articles for article (PubMed ID: 21106034)
1. Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery.
Daragó A; Fagyas M; Siket IM; Facskó A; Megyesi Z; Kalász J; Galajda Z; Szerafin T; Hársfalvi J; Edes I; Papp Z; Tóth A; Szentmiklósi J
Cardiovasc Ther; 2012 Jun; 30(3):136-44. PubMed ID: 21106034
[TBL] [Abstract][Full Text] [Related]
2. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery.
Nishimoto M; Takai S; Sawada Y; Yuda A; Kondo K; Yamada M; Jin D; Sakaguchi M; Asada K; Sasaki S; Miyazaki M
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):729-34. PubMed ID: 11279415
[TBL] [Abstract][Full Text] [Related]
3. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts.
Borland JA; Chester AH; Crabbe S; Parkerson JB; Catravas JD; Yacoub MH
J Thorac Cardiovasc Surg; 1998 Aug; 116(2):206-12. PubMed ID: 9699571
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
[TBL] [Abstract][Full Text] [Related]
5. Radial artery graft patency relates to gender, diabetes mellitus and angiotensin inhibition.
Bartnes K; Hermansen SE; Dahl-Eriksen O; Iqbal A; Mannsverk JT; Steigen TK; Trovik T; Busund R; Dahl PE; Sørlie DG; Myrmel T
Scand Cardiovasc J; 2010 Aug; 44(4):230-6. PubMed ID: 20331352
[TBL] [Abstract][Full Text] [Related]
6. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
[TBL] [Abstract][Full Text] [Related]
7. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts.
Desai ND; Cohen EA; Naylor CD; Fremes SE;
N Engl J Med; 2004 Nov; 351(22):2302-9. PubMed ID: 15564545
[TBL] [Abstract][Full Text] [Related]
9. Late outcomes after radial artery versus saphenous vein grafting during reoperative coronary artery bypass surgery.
Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah AS; Engoren M; Habib RH
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1511-1518.e4. PubMed ID: 19818456
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
11. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.
Khot UN; Friedman DT; Pettersson G; Smedira NG; Li J; Ellis SG
Circulation; 2004 May; 109(17):2086-91. PubMed ID: 15123539
[TBL] [Abstract][Full Text] [Related]
12. Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial.
Hayward PA; Hare DL; Gordon I; Buxton BF
Eur J Cardiothorac Surg; 2008 Jul; 34(1):113-7. PubMed ID: 18455416
[TBL] [Abstract][Full Text] [Related]
13. Vasomotor response to ergometrine and nitrates of saphenous vein grafts, internal mammary artery grafts, and grafted coronary arteries late after bypass surgery.
Hanet C; Robert A; Wijns W
Circulation; 1992 Nov; 86(5 Suppl):II210-6. PubMed ID: 1424002
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
15. Postoperative evaluation of radial artery grafts for coronary artery bypass grafting by transit-time Doppler flow measurements.
Ennker J; Wanner M; Gehle P; Ennker IC; Rosendahl U
Thorac Cardiovasc Surg; 2001 Dec; 49(6):365-8. PubMed ID: 11745061
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
17. Choice of conduit for the right coronary system: 8-year analysis of Radial Artery Patency and Clinical Outcomes trial.
Hadinata IE; Hayward PA; Hare DL; Matalanis GS; Seevanayagam S; Rosalion A; Buxton BF
Ann Thorac Surg; 2009 Nov; 88(5):1404-9. PubMed ID: 19853082
[TBL] [Abstract][Full Text] [Related]
18. Persistent sensitivity disorders at the radial artery and saphenous vein graft harvest sites: a neglected side effect of coronary artery bypass grafting procedures.
Dick F; Hristic A; Roost-Krähenbühl E; Aymard T; Weber A; Tevaearai HT; Carrel TP
Eur J Cardiothorac Surg; 2011 Jul; 40(1):221-6. PubMed ID: 21177115
[TBL] [Abstract][Full Text] [Related]
19. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up.
Collins P; Webb CM; Chong CF; Moat NE;
Circulation; 2008 Jun; 117(22):2859-64. PubMed ID: 18506009
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide relaxes human coronary artery bypass grafts preconstricted by endothelin-1.
Kelsall CJ; Chester AH; Amrani M; Singer DR
Ann Thorac Surg; 2005 Oct; 80(4):1347-51. PubMed ID: 16181867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
